HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lewis, M. J. Articles by Woof, J. M. Search for Related Content PubMed PubMed Citation Articles by Lewis, M. J. Articles by Woof, J. M.

Structural Requirements for the Interaction of Human IgA with the Human Polymeric Ig Receptor¹

Division of Pathology and Neurosciences, University of Dundee Medical School, Ninewells Hospital, Dundee, United Kingdom

Transport of polymeric IgA onto mucosal surfaces to become secretory IgA is mediated by the polymeric Ig receptor (pIgR). To study the interaction of human dimeric IgA (dIgA) (the predominant form of IgA polymer) with the human pIgR (hpIgR), we generated recombinant wild-type dIgA1 and dIgA2m(1) and various mutant dIgA1 and analyzed their interaction with a recombinant human secretory component and membrane-expressed hpIgR. We found that wild-type dIgA1 and dIgA2m(1) bound to recombinant human secretory component with similar affinity and were transcytosed by the hpIgR to the same extent. Mutation of the IgA C2 domain residue Cys³¹¹ to Ser reduced binding to hpIgR, possibly through disruption of noncovalent interactions between the C2 domain and domain 5 of the receptor. Within the C3 domain of IgA1, we found that combined mutation of residues Phe⁴¹¹, Val⁴¹³, and Thr⁴¹⁴, which lie close to residues previously implicated in hpIgR binding, abolished interaction with the receptor. Mutation of residue Lys³⁷⁷, located very close to this same region, perturbed receptor interaction. In addition, 4 aa (Pro⁴⁴⁰-Phe⁴⁴³), which lie on a loop at the domain interface and form part of the binding site for human FcRI, appear to contribute to hpIgR binding. Lastly, use of a monomeric IgA1 mutant lacking the tailpiece revealed that the tailpiece does not occlude hpIgR-binding residues in IgA1 monomers. This directed mutagenesis approach has thus identified motifs lying principally across the upper surface of the C3 domain (i.e., that closest to C2) critical for human pIgR binding and transcytosis.

This article has been cited by other articles:

				P. A. Ramsland, N. Willoughby, H. M. Trist, W. Farrugia, P. M. Hogarth, J. D. Fraser, and B. D. Wines Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1 PNAS, September 18, 2007; 104(38): 15051 - 15056. [Abstract] [Full Text] [PDF]

				N. J. Mantis, J. Palaia, A. J. Hessell, S. Mehta, Z. Zhu, B. Corthesy, M. R. Neutra, D. R. Burton, and E. N. Janoff Inhibition of HIV-1 Infectivity and Epithelial Cell Transfer by Human Monoclonal IgG and IgA Antibodies Carrying the b12 V Region J. Immunol., September 1, 2007; 179(5): 3144 - 3152. [Abstract] [Full Text] [PDF]

				B. W. Senior and J. M. Woof Sites in the CH3 Domain of Human IgA1 That Influence Sensitivity to Bacterial IgA1 Proteases J. Immunol., September 15, 2006; 177(6): 3913 - 3919. [Abstract] [Full Text] [PDF]